Considering improvement of myocardial performance due to CRT (increase of LVEF) strongly correlates with decreasing MPO levels in CHF patients, our data imply that this improvement is promoted by anti-inflammatory effects as described before in several studies [10, 18, 19]. The gene discussed is MPO; the disease is congestive heart failure.